Last reviewed · How we verify

NCT06237543: TAPSE/PASP

TAPSE/PASP Anesthesia

Status unknown Last updated 1 February 2024
What this trial tests

trial testing hypotension in Hypotension in 52 participants. Status unknown.

Timeline
1 February 2024
Primary endpoint
1 February 2025
1 February 2026

Quick facts

Lead sponsorAydin Adnan Menderes University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment52
Start date1 February 2024
Primary completion1 February 2025
Estimated completion1 February 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Aydin Adnan Menderes University

Who can join

Adults 18 to 75, any sex, with Hypotension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

TAPSE, one of the methods for evaluating right ventricular systolic function; It is a bar parameter that can easily measure apex-basal shortening and provides specific information about global RV function. TAPSE/PASP can be calculated as load-independent parameters to evaluate RV function. Because RV function is sensitive to change in afterload, known as the RV-pulmonary circulation (PC) connection. This study aims to identify patients who are candidates for hypotensive events due to general anesthesia in a hemodynamically stable population.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hypotension

Currently open trials in the same condition.

Other Aydin Adnan Menderes University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06237543.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing